Preventive Vaccines Market Share

Statistics for the 2023 & 2024 Preventive Vaccines market share, created by Mordor Intelligence™ Industry Reports. Preventive Vaccines share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Finished Dosage Form Research Vaccines Research Preventive Vaccines Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Preventive Vaccines Industry

The preventive vaccines market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the key players in the market are AstraZeneca PLC, Emergent BioSolutions Inc., Daiichi Sankyo Co. Ltd, GSK PLC, Johnson & Johnson, Merck & Co., Novavax Inc., Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd, among others.

Preventive Vaccines Market Leaders

  1. AstraZeneca PLC

  2. Emergent BioSolutions Inc

  3. Johnson & Johnson

  4. Merck & Co

  5. GSK Plc

*Disclaimer: Major Players sorted in no particular order

Preventive Vaccines Market Concentration

Preventive Vaccines Market Report Snapshots

Preventive Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)